BMC Primary Care

Table 3 Changes within groups in primary and secondary outcome measures⁰

From: The effectiveness of the Austrian disease management programme for type 2 diabetes: a cluster-randomised controlled trial

Reduction of	Intervention				Control
	n¹	mean²	95% CI	p-value³	n¹	mean	95% CI	p-value³
primary outcome measure
HbA1c (%)	590	0.41	[0.32; 0.50]	<0.0001	754	0.28	[0.21; 0.35]	<0.0001
secondary outcome measures
Creatinine (μmol/l)	586	-0.88	[-2.65; 0.88]	0.165	739	0.88	[-0.88; 2.65]	0.504
Triglycerides (mmol/l)	585	0.15	[0.02; 0.27]	0.021	736	0.09	[0.00; 0.17]	0.046
Cholesterol (mmol/l)	585	0.06	[-0.01; 0.14]	0.112	736	0.01	[-0.06; 0.07]	0.797
HDL (mmol/l)	585	-0.02	[-0.04; -0.01]	0.011	736	-0.01	[-0.03; 0.01]	0.209
LDL (mmol/l)	585	-0.01	[-0.08; 0.07]	0.864	736	0.04	[-0.02; 0.10]	0.161
RR systolic (mmHg)	561	2.49	[1.03; 3.94]	0.001	691	0.68	[-0.46; 1.83]	0.241
RR diastolic (mmHg)	561	1.16	[0.35; 1.98]	0.005	691	0.61	[-0.08; 1.30]	0.084
BMI	568	0.31	[0.17; 0.44]	<0.001	695	0.04	[-0.09; 0.16]	0.540

⁰ Reduction is shown as positive number.
¹ n per protocol
² intention to treat
³ paired T-Test

Back to article page

ISSN: 2731-4553

Contact us

General enquiries: journalsubmissions@springernature.com